Cytosurge Announces Strategic Leadership Transition Cytosurge appoints Simon Egli as CEO; co-founder Pascal Behr transitions to Board to ensure strategic guidance and growth.

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing Cytosurge and Lexogen partner to advance Live-seq, integrating FluidFM® and LUTHOR HD to enable scalable, live-cell transcriptomics with high sensitivity.